Indian Journal of Health Sciences and Biomedical Research KLEU (Jan 2022)

Immunological characteristics of CoVID-19 and its implications

  • Amrita Ghosh,
  • Ranabir Pal,
  • Ray Elizabeth Dominic,
  • Mugdha Mittal,
  • Luis Rafael Moscote-Salazar,
  • Bukkambudhi V Murlimanju,
  • Rafael Cincu,
  • Amit Agrawal

DOI
https://doi.org/10.4103/kleuhsj.kleuhsj_126_22
Journal volume & issue
Vol. 15, no. 3
pp. 204 – 210

Abstract

Read online

CoVID-19 is the most formidable unequaled global challenge invading 220 countries and territories in this millennium to uncountable saga of mortality, disability as humanity is witnessing devastation of socio-economy with more than 4 million deaths till date. The natural history of CoVID-19 from transmission through varied clinical features to overt complications is still under global research and research groups are on the run to trace its ramifications. This ranges from primary involvement of the pulmonary system to multisystem involvement through web of immunological pathways associated with susceptibility, clinical presentations, and severity of COVID-19. It has been hypothesized that the safe and effective mass vaccination program across the globe can ensure flattening of the pandemic curve to prepandemic normal life. This research group explored the basic and applied researches on molecular and immune mechanisms of SARS COV-2 virus. A sincere attempt has been made in futuristic research vision to find potential strengths, shortfalls, and efficacy of the plant-based immunotherapy, antibodies, and vaccine. Different research groups have hypothesized for the best possible use of these indigenous, stable, secure, efficacious natural products by searching their potential to accomplish emergency demands in this trying time. There is an urgent need to understand the inherent immunological predictors of the natural history of the disease spread over the spectrum from mild to severe forms of the disease and harp on these issues. In the wake of multiple waves with worse situations of evolving clinical features with the “variants of concern” and “variants of interest” and innovative interventions, this research group believes in optimum mix of microbial-derived biologicals with immune modifying drugs will broaden the preventive and curative spectrum.

Keywords